Biotech and bio generic APIs Market, trends, emerging countries, technologies

摘要

Biotech APIs set for growth, and even more bio generic APIs (also called bio similar APIs); but the rates of growth of the market for these products are expected to be quite different between the "emerging" and the "industrialised" countries. For bio generic APIs all is not so rosy in Western-areas in the short term. This sets the emerging countries (particularly Far Eastern countries) in a favourable position to capitalise in the bio generic sector. The production technologies applied to the pharmaceutical industry are becoming every day more sustainable and cost - effective. What kind of future for biotech pharmaceuticals and biotechnologies?